Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant

Integra LifeSciences Corporation110 enrolled

Overview

A Prospective, Multicenter Observational Study Evaluating the Long Term Safety in Terms of Explantation Rate and Number of Infections of the Custom-made Bioceramic Implant CustomBone™ The patients will be included as soon as they are implanted and follow-up for 2 years. It is observational so no specific exam is planned. The explantation rate will be measured, that is to say the number of patients whose prosthesis will be removed (with or without any relationship with the implant or the procedure).

Study Type

OBSERVATIONAL

Enrollment

110

Conditions

Surgery

Interventions

craniectomyPROCEDURE

craniectomy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patient planning to have a cranioplasty and be implanted with the Custombone™ medical device * Patient who agrees to take part in the study, or agreement of a representative of the patient in case of patient inability, after being informed by the investigator and having received an information letter Exclusion criteria: \- Patient who does not accept to take part in the study after being informed

Locations (18)

CH Amiens

Amiens, France

CHU Angers

Angers, France

CH de la cote basque

Bayonne, France

Outcomes

Primary Outcomes

Explantation rate after 2 years of follow-up

The main objective of the study is to measure the explantation rate after the implantation of a Custombone TM prosthesis. We will measure the number of patients whose prosthesis has an been removed, with or without any relationship with the implant or the procedure

Time frame: 24 months after implantation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.